Skip to main content

Advertisement

SpringerLink
Log in

Provision of pharmaceuticals in Australian hospitals: equity of access?

  • Commentary
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

In Australia, medicines are funded under a complex set of financial arrangements. Currently there are dual funding arrangements in public and private hospitals that can lead to differences in patient access to medications. There are considerable concerns about the consequences of the fragmentation and “lack of cohesion of the system”. Some decision-makers consider there are inequities because of the funding models in place. What follows is a description of this system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Salked G, Mitchell A, Hill S. Pharmaceuticals. In: Mooney G, Scotton R, editors. Economics and Australian health policy. St Leonards: Allen & Unwin; 1999. ISBN 1 86448 749 6

  2. Commonwealth Department of Health and Ageing. National medicines policy. 2000; http://www.health.gov.au/internet/wcms/publishing.nsf/Content/nmp-objectives-policy.htm/$FILE/nmp2000.pdf (7 September 2006)

  3. Department of Health and Ageing. TGA – therapeutics goods administration. 2006; http://www.tga.gov.au/docs/html/pmeds_reg.htm (7 September 2006)

  4. Duckett SJ. Australian hospital services: An overview. Aust Health Rev 2002; 25(1):2–18

    Google Scholar 

  5. Department of Health Government of Western Australia. Pharmaceutical benefit scheme (PBS) reform. 2006; http://www.health.wa.gov.au/pbsreform/ (7 September 2006)

  6. Department of Health and Ageing. Annual report 2003–2004. Australian health care agreements. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/14C0682D7DFA0F66CA25718E001BCBCC/$File/ar2003-04_full.pdf (7 September 2006)

  7. Sansom L. The subsidy of pharmaceuticals in Australia: processes and challenges. Aust Health Rev 2004; 28(2):194–205

    Article  PubMed  Google Scholar 

  8. Commonwealth Department of Health and Aged Care. Guidelines for the pharmaceutical industry preparation of submissions to the Pharmaceutical Benefits advisory committee. Canberra: Commonwealth Department of Health and Ageing; 2002. ISBN 0 642 82144 5

    Google Scholar 

  9. Commonwealth Department of Health and Ageing. Schedule of Pharmaceutical Benefits – Section 100 arrangements. 2006; http://www.health.gov.au/internet/wcms/publishing.nsf/content/pbs-schedule-sec100 (7 September 2006)

  10. Victorian Government Health Information. Commonwealth/State highly specialised drugs program guidelines. 2006; http://www.health.vic.gov.au/hsdp/program.htm#Anchor-Program-5249 (7 September 2006)

  11. Donato R, Scotton R. The Australian health care system. In: Mooney G, Scotton R. editors. Economics and Australian health policy. St Leonards, NSW: Allen & Unwin; 1999. ISBN 1 86448 749 6

  12. Department of Health and Ageing. Australian health care agreements. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/Australian+Health+Care+Agreements-1 (7 September 2006)

  13. Department of Health and Ageing. The state of our public hospitals, June 2004 report. http://www.health.gov.au/internet/WCMS/publishing.nsf/Content/health-ahca-sooph-index.htm/$FILE/sooph2004.pdf (7 September 2006)

  14. Australian Institute of Health and Welfare (AIHW). Australia’s health 2004. Canberra: AIHW; 2004. ISBN 1 74024 382 X

    Google Scholar 

  15. Australian Bureau of Statistics. Year book Australia. Health care delivery and financing. 2006; http://www.abs.gov.au/Ausstats/abs@.nsf/94713ad445ff1425ca25682000192af2/98de259e1e8f1cb3ca256f7200832f37!OpenDocument (7 September 2006)

  16. McAuley I. Stress on public hospitals – why private insurance has made it worse. Canberra: Australian Consumers Association and the Australian Healthcare Association; 2004

    Google Scholar 

  17. Blendon RJ, Schoen C, DesRoches CM, Osborn R, Zapert K, Raleigh E. Confronting competing demands to improve quality: a five-country hospital survey. Health Aff 2004; 23(3):119–135

    Article  Google Scholar 

  18. Royal Australasian College of Physicians. Response to the senate inquiry into public hospital funding. Sydney: Royal Australasian College of Physicians; 1999

    Google Scholar 

  19. Duckett SJ, Jackson TJ. The new health insurance rebate: an inefficient way of assisting public hospitals. Med J Aust 2000; 172(9):439–442

    PubMed  CAS  Google Scholar 

  20. The Society of Hospital Pharmacists of Australia (SHPA). Moving forward – the funding of medicines in Australia’s hospitals. Melbourne: The Society of Hospital Pharmacists of Australia (SHPA); 2004

    Google Scholar 

  21. National Health Strategy. Issues in pharmaceutical drug use in Australia. Issue paper no.4. Canberra: Department of Health, Housing and Community Services; 1992. ISBN

    Google Scholar 

  22. Commonwealth Department of Health and Aged Care. The Australian health care system, an outline. Canberra: ACT, Publications Unit, Commonwealth Department of Health and Aged Care; 2000. ISBN 0 642 44730 6

  23. Victorian Therapeutic Advisory Group VicTAG. Hospital price and resource allocation review: good practice model for controlling medicines costs in hospitals. Melbourne: Victorian Therapeutics Advisory Group; 2004

  24. Australian Institute of Health and Welfare (AIHW). Australian hospital statistics 2002–2003. Canberra: AIHW; 2004. ISBN 1036-613X

    Google Scholar 

  25. Commonwealth Department of Health and Ageing. Schedule of pharmaceutical benefits for approved pharmacists and medical practitioners – chemotherapy pharmaceuticals access program supplement. http://www.health.gov.au/internet/wcms/publishing.nsf/Content/986ABF111B7A5183CA256F180048C850/$File/pbschemo_aug06.pdf (7 September 2006)

  26. O’Leary KM, Allison YM. Pharmacy distribution service delivery models in use in Australian public. J Pharm Pract Res 2004; 34(2):114–121

    Google Scholar 

  27. Larmour I, Thomson WA, TSui MK, Weeks GR. Introduction of Pharmaceutical Benefits scheme reforms at three Victorian public health services. J Pharm Pract Res 2003; 33:204–207

    Google Scholar 

  28. Senate Community Affairs Reference Committee. Public founding and options for reform. First report. Canberra: Senate Community Affairs Reference Committee; 2000. ISBN 0 642 71044 9

  29. Low J. Negotiating access to PBS medicines in public hospitals. Aust J Pharm 2003; 84(December):928

    Google Scholar 

  30. Department of Health Government of Western Australia. Western Australia drugs and therapeutics committee (WATAG). http://www.watag.org.au/home/ (7 September 2006)

  31. Queensland Government (Queensland Health). Queensland health policy/guidelines. Availability of pharmaceuticals. http://www.health.qld.gov.au/phs/Documents/pas/566.pdf (7 September 2006)

  32. Hall J. Incremental change in the Australian health care system. Health Aff 1999; 18(3):95–110

    Article  CAS  Google Scholar 

  33. Allinson Y. Funding of pharmaceuticals in public hospitals: PBS under the probe. Healthcover 2001; 11(2):58–63

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Health Economics Research and Evaluation (CHERE), University of Technology, Sydney, PO Box 123, Broadway, NSW, 2007, Australia

    Gisselle Gallego

  2. Faculty of Pharmacy, The University of Sydney, A15 – Pharmacy, Camperdown, NSW, 2006, Australia

    Susan J. Taylor & Jo-anne E. Brien

  3. Pfizer Australia Chair in Clinical Pharmacy (St Vincent’s Hospital), Therapeutics Centre, St Vincent’s Hospital, Level 2, Xavier Building, Darlinghurst, NSW, 2010, Australia

    Jo-anne E. Brien

Authors
  1. Gisselle Gallego
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Susan J. Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jo-anne E. Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gisselle Gallego.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallego, G., Taylor, S.J. & Brien, Ja.E. Provision of pharmaceuticals in Australian hospitals: equity of access?. Pharm World Sci 29, 47–50 (2007). https://doi.org/10.1007/s11096-006-9066-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-006-9066-y

Keywords

Search

Navigation